Skip to search.
 TSX Up 0.31% TSX Ventures Up 1.24%

Gilead Sciences Inc. (GILD)

-NasdaqGS
88.79 Down 8.21(8.47%) 1:53PM EDT - Nasdaq Real Time Price
Prev Close:97.00
Open:91.19
Bid:89.55 x 500
Ask:89.56 x 500
1y Target Est:114.29
Beta:1.25203
Earnings Date:Jul 26 - Aug 1 (Est.)
Day's Range:88.23 - 92.53
52wk Range:81.89 - 123.37
Volume:21,463,007
Avg Vol (3m):12,300,400
Market Cap:120.27B
P/E (ttm):7.45
EPS (ttm):11.91
Div & Yield:1.72 (1.68%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
GILDDown 8.47%120.27B
GSKDown 1.13%103.74B
PFEDown 0.91%201.92B

Key Statistics

Forward P/E (1 yr):7.19
P/S (ttm):4.06
Ex-Dividend Date:14-Mar-16

Analysts

Annual EPS Est (Dec-16) :12.33
Quarterly EPS Est (Jun-16) :3.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):6.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback